Utility of cenegermin for the management of neurotrophic keratopathy after penetrating keratoplasty

BACKGROUND: The study aimed to report the outcomes of patients treated with cenegermin 0.002% for neurotrophic keratopathy (NK) following penetrating keratoplasty (PK). MATERIALS AND METHODS: This retrospective case series included patients evaluated at a tertiary care hospital who completed an 8-we...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexandra R. Zaloga, Ashley Khalili, Brandon D. Ayres, Brenton D. Finklea, Beeran B. Meghpara, Christopher J. Rapuano, Zeba A. Syed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-05-01
Series:Oman Journal of Ophthalmology
Subjects:
Online Access:https://journals.lww.com/10.4103/ojo.ojo_311_24
Tags: Add Tag
No Tags, Be the first to tag this record!